Literature DB >> 3285012

Clonal heterogeneity, experimental metastatic ability, and p21 expression in H-ras-transformed NIH 3T3 cells.

S A Hill1, S Wilson, A F Chambers.   

Abstract

We examined individual clones of murine NIH 3T3 cells, transformed with the human bladder cancer (T24) H-ras oncogene, for p21 expression and for experimental metastatic ability in the immunodeficient chick embryo. We found that the clones were heterogeneous for both of these properties. In general, p21 expression was a good predictor of metastatic ability of the clones. Cells from poorly metastatic clones were passaged in the chick embryo metastasis assay to determine whether cells with increased metastatic ability could be selected. We found that the selected cells were more metastatic and that substantial increases in expression of p21 also accompanied this increase in metastatic ability. The relationship between p21 expression and metastatic ability appeared linear, with a high correlation coefficient (r = .85), suggesting that in this model system quantitative increases in metastatic properties can result from increased expression of the ras oncogene protein product p21.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3285012     DOI: 10.1093/jnci/80.7.484

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  15 in total

1.  Traction force microscopy of migrating normal and H-ras transformed 3T3 fibroblasts.

Authors:  S Munevar; Y Wang ; M Dembo
Journal:  Biophys J       Date:  2001-04       Impact factor: 4.033

2.  Persistence of Ha-ras-induced metastatic potential of SP1 mouse mammary tumors despite loss of the Ha-ras shuttle vector.

Authors:  B Schlatter; C G Waghorne
Journal:  Proc Natl Acad Sci U S A       Date:  1992-11-01       Impact factor: 11.205

3.  Cell motility and local viscoelasticity of fibroblasts.

Authors:  S Park; D Koch; R Cardenas; J Käs; C K Shih
Journal:  Biophys J       Date:  2005-09-30       Impact factor: 4.033

4.  Cellular responses to substrate topography: role of myosin II and focal adhesion kinase.

Authors:  Margo T Frey; Irene Y Tsai; Thomas P Russell; Steven K Hanks; Yu-Li Wang
Journal:  Biophys J       Date:  2006-02-24       Impact factor: 4.033

5.  Independence of metastatic ability and extravasation: metastatic ras-transformed and control fibroblasts extravasate equally well.

Authors:  S Koop; E E Schmidt; I C MacDonald; V L Morris; R Khokha; M Grattan; J Leone; A F Chambers; A C Groom
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

6.  Daple is a novel non-receptor GEF required for trimeric G protein activation in Wnt signaling.

Authors:  Nicolas Aznar; Krishna K Midde; Ying Dunkel; Inmaculada Lopez-Sanchez; Yelena Pavlova; Arthur Marivin; Jorge Barbazán; Fiona Murray; Ulrich Nitsche; Klaus-Peter Janssen; Karl Willert; Ajay Goel; Miguel Abal; Mikel Garcia-Marcos; Pradipta Ghosh
Journal:  Elife       Date:  2015-06-30       Impact factor: 8.140

Review 7.  Tumor progression: potential role of unstable genomic changes.

Authors:  R P Hill
Journal:  Cancer Metastasis Rev       Date:  1990-09       Impact factor: 9.264

8.  ras transfection and expression does not induce progression from tumorigenicity to metastatic ability in mouse LTA cells.

Authors:  A B Tuck; S M Wilson; A F Chambers
Journal:  Clin Exp Metastasis       Date:  1990 Sep-Oct       Impact factor: 5.150

9.  Genetic factors and suppression of metastatic ability of v-Ha-ras-transfected rat mammary cancer cells.

Authors:  T Ichikawa; Y Ichikawa; J T Isaacs
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-01       Impact factor: 11.205

10.  Farnesylamine: an inhibitor of farnesylation and growth of ras-transformed cells.

Authors:  R Kothapalli; N Guthrie; A F Chambers; K K Carroll
Journal:  Lipids       Date:  1993-11       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.